Cargando…
Regulatory assessment of nano-enabled health products in public health interest. Position of the scientific advisory board of the French National Agency for the Safety of Medicines and Health Products
Nanomaterials are present in a wide variety of health products, drugs and medical devices and their use is constantly increasing, varying in terms of diversity and quantity. The topic is vast because it covers nanodrugs, but also excipients (that includes varying proportions of NMs) and medical devi...
Autores principales: | Oualikene-Gonin, Wahiba, Sautou, Valérie, Ezan, Eric, Bastos, Henri, Bellissant, Eric, Belgodère, Laëtitia, Maison, Patrick, Ankri, Joël |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018019/ https://www.ncbi.nlm.nih.gov/pubmed/36935690 http://dx.doi.org/10.3389/fpubh.2023.1125577 |
Ejemplares similares
-
Patient and public involvement in the benefit–risk assessment and decision concerning health products: position of the Scientific Advisory Board of the French National Agency for Medicines and Health Products Safety (ANSM)
por: Belgodère, Laëtitia, et al.
Publicado: (2023) -
Prevention and management of health products shortages by the French national agency (ANSM), 10 years of experience
por: Belgodère, Laëtitia, et al.
Publicado: (2023) -
244 “I am interested!”: Lessons Learned from the All IN for Health/Indiana CTSI Health Advisory Board
por: Sotto-Santiago, Sylk, et al.
Publicado: (2023) -
Advisory boards in startups: investigating the roles of advisory boards in German technology-based startups
por: Weber, Eric
Publicado: (2016) -
Advisory Board and Contents
Publicado: (2020)